ClinicalTrials.govpublic full text
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
melanoma, non-small sell lung cancer (nsclc), triple negative breast cancer, anaplastic thyroid cancer, other solid tumors, phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1, nsclc, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843736
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.